Virtuix Holdings Inc. (VTIX) SEC filings document the company’s public reporting as a Nasdaq-listed emerging growth company focused on AI-driven full-body simulation systems. Its filings identify common stock trading on the Nasdaq Global Market under VTIX and provide regulatory detail behind company updates about Omni One, defense applications, operating results, governance, and financing arrangements.
Quarterly reports are especially relevant for Virtuix because they include revenue recognition policies, contract descriptions, financial statements, risk language, and going-concern disclosure. The company’s filings state that contracts typically include product sales, installation services, support programs, or digital playtime credits, and that most contracts involve transferring or installing physical goods.
Virtuix 8-K filings report material events such as operating results, business development updates, auditor changes, board matters, and warrant amendments. Proxy materials provide stockholder meeting information and governance disclosures. Notices of late filing, amended quarterly reports, and other periodic filings give additional context when the timing or content of reports changes.
For VTIX, useful filing review areas include Form 10-Q reports, 8-K event disclosures, proxy statements, capital structure items, revenue policies, auditor transitions, and any Form 4 insider transaction reports filed for company insiders. Together, these filings show how Virtuix presents its business, obligations, and risk disclosures in the SEC record.
MOYER BRETT reported acquisition or exercise transactions in this Form 4 filing.
Virtuix Holdings Inc. reported that director Brett Moyer received an equity grant of 16,600 restricted stock units (RSUs) for Board service under the 2025 Omnibus Incentive Plan. These RSUs vest in full on March 13, 2027, one year after the grant date, subject to continued service. Each RSU represents a contingent right to receive one share of Virtuix’s Class A common stock, so this is a stock-based compensation award rather than an open-market share purchase.
Virtuix Holdings Inc. director Brett Moyer filed an initial Form 3, which is a required statement of beneficial ownership for company insiders. This filing lists him as a director but shows no reported transactions or derivative positions in the data provided.
Virtuix Holdings Inc. registers the resale of up to 34,213,618 shares of Class A common stock in connection with its direct listing on the Nasdaq Global Market.
The Sticker Supplement updates the Prospectus to disclose amendments to warrants held by Streeterville Capital, LLC that extend a reduced exercise price period to $6.00 per warrant share for an additional 90 days from March 12, 2026 through June 10, 2026, subject to earlier termination on two trading days' written notice. All other warrant terms remain unchanged.
Virtuix Holdings Inc. has amended several existing warrants held by Streeterville Capital, LLC to extend a previously established reduced exercise price period. During this period, the exercise price for each warrant remains reduced to $6.00 per Warrant share.
The extended reduced exercise price period now runs for ninety days from March 12, 2026 through June 10, 2026. Virtuix can end this discounted period at any time by giving two trading days’ written notice, after which the exercise price will revert to the original Nasdaq Valuation Price defined in each warrant.
All other terms of the Equity Financing Warrant, Second Debt Financing Warrant, and Third Debt Financing Warrant remain unchanged, with the detailed amendments filed as exhibits to the report.
Virtuix Holdings Inc. reported strong year-over-year growth for the nine months ended December 31, 2025, while remaining loss-making. Net sales rose 41% to $3.0 million, driven by Omni One demand and a strong 2025 holiday season.
Gross profit improved to $0.9 million and gross margin jumped to 29% from (17%) as higher pricing and reduced discounted units took effect. Total operating expenses fell 45% to $6.3 million, mainly from lower general and administrative and R&D spending, partially offset by higher selling expenses.
Net loss narrowed to ($6.9) million from ($12.0) million, with prior-year results including a large non-cash stock-based charge. Cash and cash equivalents were $1.1 million as of December 31, 2025, against total liabilities of $9.3 million and a stockholders’ deficit of ($3.0) million.
The company highlighted manufacturing capacity for up to 3,000 Omni One units per month and recent milestones, including its Nasdaq listing under the symbol “VTIX,” a Made for Meta collaboration to reach Quest headset users, European expansion, and early defense adoption of its Virtual Terrain Walk system. Virtuix also appointed Brett Moyer as an independent Class III director, with standard cash and equity compensation.
Virtuix Holdings Inc. director and Chief Executive Officer Jan Goetgeluk reported an internal share conversion. On March 6, 2026, he converted 500,000 shares of Class B common stock into 500,000 shares of Class A common stock, with each Class B share convertible 1-for-1 into Class A. Following this conversion, his reported direct holdings of Class A common stock were 507,488 shares.
Virtuix Holdings Inc. (VTIX) continued to grow revenue but remained deeply unprofitable and flagged going concern risks. For the nine months ended December 31, 2025, net sales rose to $2,980,765 from $2,110,889, driven mainly by Omni One home VR systems and related services.
Despite higher sales and improved gross profit, the company reported a net loss of $(6,892,302), following a $(12,024,068) loss a year earlier, and an accumulated deficit of $(69,384,892). Management disclosed that recurring losses, limited working capital, and liquidity pressures raise “substantial doubt” about its ability to continue as a going concern.
To bolster liquidity, Virtuix issued multiple high‑cost and convertible notes, including secured promissory notes to Streeterville Capital and subordinated investor notes, many with original issue discounts and associated equity warrants. Subsequent to quarter‑end, its Nasdaq direct listing became effective, triggering an initial $8,000,000 advance under an equity financing agreement and several warrant exercises and note conversions into Class A common stock.
Virtuix Holdings Inc. reported a major growth milestone and product expansion, highlighting its Omni One virtual reality treadmill system. The company is launching Omni One Core sales across Europe, including Germany, the UK, France and other EU countries, with first shipments scheduled between April 13 and April 24, 2026.
Omni One Core is priced at €2,995 in EU countries and £2,795 in the UK and is supported by a regional logistics and fulfillment partnership with Unbound XR. Virtuix noted 138% year-over-year revenue growth for the six months ended September 30, 2025, production capacity of up to 3,000 units per month and approximately $100 million in annual revenue potential.
The company also recently listed on Nasdaq under the symbol VTIX and secured an $11 million investment to support sales, marketing and product development, positioning it to scale international demand for Omni One.
Virtuix Holdings Inc. has filed a sticker supplement covering the resale of up to 34,213,618 shares of its Class A common stock by existing stockholders in connection with its direct listing on the Nasdaq Global Market under the symbol VTIX.
The supplement also discloses amendments to certain warrants held by Streeterville Capital, LLC, temporarily reducing the exercise price to $6.00 per share for exercises from February 9, 2026 through March 11, 2026, after which the exercise price reverts to the original Nasdaq Valuation Price.
Virtuix Holdings Inc. entered into amendments to four existing warrants with Streeterville Capital, LLC that temporarily reduce the exercise price. For any exercises from February 9, 2026 through March 11, 2026, the warrants may be exercised at $6.00 per Warrant Share. After this Reduced Exercise Price Period ends, the exercise price reverts to the Nasdaq Valuation Price specified in the original warrants. All other warrant terms remain unchanged, and the amendments are filed as exhibits to the report.